![IG7 IG7](https://data.pdbj.org/pdbjplus/data/cc/svg/IG7.svg) | IG7 | Name: | [(2~{S})-3-[(2~{S})-3-azanyl-2-(hexadecanoylamino)-3-oxidanylidene-propyl]sulfanyl-2-hexadecanoyloxy-propyl] hexadecanoate | Formula: | C54 H104 N2 O6 S | SMILES: | CCCCCCCCCCCCCCCC(=O)N[CH](CSC[CH](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC)C(N)=O | InChi: | InChI=1S/C54H104N2O6S/c1-4-7-10-13-16-19-22-25-28-31-34-37-40-43-51(57)56-50(54(55)60)48-63-47-49(62-53(59)45-42-39-36-33-30-27-24-21-18-15-12-9-6-3)46-61-52(58)44-41-38-35-32-29-26-23-20-17-14-11-8-5-2/h49-50H,4-48H2,1-3H3,(H2,55,60)(H,56,57)/t49-,50+/m0/s1 | Definition date: | 2022-03-18 | Last modified: | 2022-10-05 | Release date: | 2022-09-07 | Identifier: | [(2~{S})-3-[(2~{S})-3-azanyl-2-(hexadecanoylamino)-3-oxidanylidene-propyl]sulfanyl-2-hexadecanoyloxy-propyl] hexadecanoate |
|
![33E 33E](https://data.pdbj.org/pdbjplus/data/cc/svg/33E.svg) | 33E | Name: | 4-iodo-3-nitrobenzamide | Formula: | C7 H5 I N2 O3 | SMILES: | Ic1ccc(cc1[N+](=O)[O-])C(=O)N | InChi: | InChI=1S/C7H5IN2O3/c8-5-2-1-4(7(9)11)3-6(5)10(12)13/h1-3H,(H2,9,11) | Synonyms: | Iniparib | Definition date: | 2014-06-06 | Last modified: | 2022-10-05 | Release date: | 2014-10-15 | Identifier: | 4-iodo-3-nitrobenzamide |
|
![IRM IRM](https://data.pdbj.org/pdbjplus/data/cc/svg/IRM.svg) | IRM | Name: | 1,2-Dihydro-psi,psi-caroten-1-ol | Formula: | C40 H58 O | SMILES: | CC(C)=CCCC(C)=CC=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC=C(C)CCCC(C)(C)O | InChi: | InChI=1S/C40H58O/c1-33(2)19-13-22-36(5)25-16-28-37(6)26-14-23-34(3)20-11-12-21-35(4)24-15-27-38(7)29-17-30-39(8)31-18-32-40(9,10)41/h11-12,14-17,19-21,23-30,41H,13,18,22,31-32H2,1-10H3/b12-11+,23-14+,24-15+,28-16+,29-17+,34-20+,35-21+,36-25+,37-26+,38-27+,39-30+ | Synonyms: | Rhodopin | Definition date: | 2022-04-07 | Last modified: | 2022-10-05 | Release date: | 2022-10-05 | Identifier: | (6~{E},8~{E},10~{E},12~{E},14~{E},16~{E},18~{E},20~{E},22~{E},24~{E},26~{E})-2,6,10,14,19,23,27,31-octamethyldotriaconta-6,8,10,12,14,16,18,20,22,24,26,30-dodecaen-2-ol |
|
![9B0 9B0](https://data.pdbj.org/pdbjplus/data/cc/svg/9B0.svg) | 9B0 | Name: | [(2~{S},3~{S},4~{E},6~{S},7~{R},10~{R})-3,7-dimethyl-2-[(2~{E},4~{E},6~{R})-6-methyl-6-oxidanyl-7-[(2~{R},3~{R})-3-[(2~{R},3~{S})-3-oxidanylpentan-2-yl]oxiran-2-yl]hepta-2,4-dien-2-yl]-7,10-bis(oxidanyl)-12-oxidanylidene-1-oxacyclododec-4-en-6-yl] 4-cycloheptylpiperazine-1-carboxylate | Formula: | C40 H66 N2 O9 | SMILES: | CC[CH](O)[CH](C)[CH]1O[CH]1C[C](C)(O)C=CC=C(C)[CH]2OC(=O)C[CH](O)CC[C](C)(O)[CH](OC(=O)N3CCN(CC3)C4CCCCCC4)C=C[CH]2C | InChi: | InChI=1S/C40H66N2O9/c1-7-32(44)29(4)37-33(49-37)26-39(5,47)19-12-13-27(2)36-28(3)16-17-34(40(6,48)20-18-31(43)25-35(45)51-36)50-38(46)42-23-21-41(22-24-42)30-14-10-8-9-11-15-30/h12-13,16-17,19,28-34,36-37,43-44,47-48H,7-11,14-15,18,20-26H2,1-6H3/b17-16+,19-12+,27-13+/t28-,29+,31+,32-,33+,34-,36+,37+,39-,40+/m0/s1 | Definition date: | 2018-03-01 | Last modified: | 2022-10-04 | Release date: | 2018-03-21 | Identifier: | [(2~{S},3~{S},4~{E},6~{S},7~{R},10~{R})-3,7-dimethyl-2-[(2~{E},4~{E},6~{R})-6-methyl-6-oxidanyl-7-[(2~{R},3~{R})-3-[(2~{R},3~{S})-3-oxidanylpentan-2-yl]oxiran-2-yl]hepta-2,4-dien-2-yl]-7,10-bis(oxidanyl)-12-oxidanylidene-1-oxacyclododec-4-en-6-yl] 4-cycloheptylpiperazine-1-carboxylate |
|
![2KW 2KW](https://data.pdbj.org/pdbjplus/data/cc/svg/2KW.svg) | 2KW | Name: | 3-chloro-5-({1-[(4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)methyl]-2-oxo-4-(trifluoromethyl)-1,2-dihydropyridin-3-yl}oxy)benzonitrile | Formula: | C17 H11 Cl F3 N5 O3 | SMILES: | FC(F)(F)C2=C(Oc1cc(C#N)cc(Cl)c1)C(=O)N(C=C2)CC3=NNC(=O)N3C | InChi: | InChI=1S/C17H11ClF3N5O3/c1-25-13(23-24-16(25)28)8-26-3-2-12(17(19,20)21)14(15(26)27)29-11-5-9(7-22)4-10(18)6-11/h2-6H,8H2,1H3,(H,24,28) | Synonyms: | Doravirine | Definition date: | 2013-11-21 | Last modified: | 2022-10-03 | Release date: | 2014-02-12 | Identifier: | 3-chloro-5-({1-[(4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)methyl]-2-oxo-4-(trifluoromethyl)-1,2-dihydropyridin-3-yl}oxy)benzonitrile |
|
![L4O L4O](https://data.pdbj.org/pdbjplus/data/cc/svg/L4O.svg) | L4O | Name: | tert-butyl (1S,4S)-2,5-diazabicyclo[2.2.1]heptane-2-carboxylate | Formula: | C10 H18 N2 O2 | SMILES: | CC(C)(C)OC(=O)N1CC2CC1CN2 | InChi: | InChI=1S/C10H18N2O2/c1-10(2,3)14-9(13)12-6-7-4-8(12)5-11-7/h7-8,11H,4-6H2,1-3H3/t7-,8-/m0/s1 | Definition date: | 2022-02-28 | Last modified: | 2022-09-30 | Release date: | 2022-10-05 | Identifier: | tert-butyl (1S,4S)-2,5-diazabicyclo[2.2.1]heptane-2-carboxylate |
|
![L4X L4X](https://data.pdbj.org/pdbjplus/data/cc/svg/L4X.svg) | L4X | Name: | Nalpha-{(2R,4E)-2-[(N-benzylglycyl)amino]-5-phenylpent-4-enoyl}-N,4-dimethyl-L-phenylalaninamide | Formula: | C31 H36 N4 O3 | SMILES: | CNC(=O)C(Cc1ccc(C)cc1)NC(=O)C(C/C=C/c1ccccc1)NC(=O)CNCc1ccccc1 | InChi: | InChI=1S/C31H36N4O3/c1-23-16-18-25(19-17-23)20-28(30(37)32-2)35-31(38)27(15-9-14-24-10-5-3-6-11-24)34-29(36)22-33-21-26-12-7-4-8-13-26/h3-14,16-19,27-28,33H,15,20-22H2,1-2H3,(H,32,37)(H,34,36)(H,35,38)/b14-9+/t27-,28+/m1/s1 | Definition date: | 2022-02-28 | Last modified: | 2022-09-30 | Release date: | 2022-10-05 | Identifier: | Nalpha-{(2R,4E)-2-[(N-benzylglycyl)amino]-5-phenylpent-4-enoyl}-N,4-dimethyl-L-phenylalaninamide |
|
![L5L L5L](https://data.pdbj.org/pdbjplus/data/cc/svg/L5L.svg) | L5L | Name: | (4R)-4-(4-methoxyphenyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine | Formula: | C14 H15 N O S | SMILES: | COc1ccc(cc1)C1NCCc2sccc21 | InChi: | InChI=1S/C14H15NOS/c1-16-11-4-2-10(3-5-11)14-12-7-9-17-13(12)6-8-15-14/h2-5,7,9,14-15H,6,8H2,1H3/t14-/m1/s1 | Definition date: | 2022-02-28 | Last modified: | 2022-09-30 | Release date: | 2022-10-05 | Identifier: | (4R)-4-(4-methoxyphenyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine |
|
![L5X L5X](https://data.pdbj.org/pdbjplus/data/cc/svg/L5X.svg) | L5X | Name: | 3-{[(5S)-5-methyl-4,5-dihydro-1,3-thiazol-2-yl]amino}phenol | Formula: | C10 H12 N2 O S | SMILES: | CC1CN=C(Nc2cc(O)ccc2)S1 | InChi: | InChI=1S/C10H12N2OS/c1-7-6-11-10(14-7)12-8-3-2-4-9(13)5-8/h2-5,7,13H,6H2,1H3,(H,11,12)/t7-/m0/s1 | Definition date: | 2022-02-28 | Last modified: | 2022-09-30 | Release date: | 2022-10-05 | Identifier: | 3-{[(5S)-5-methyl-4,5-dihydro-1,3-thiazol-2-yl]amino}phenol |
|
![L6A L6A](https://data.pdbj.org/pdbjplus/data/cc/svg/L6A.svg) | L6A | Name: | 4-azanyl-7-[3-(hydroxymethyl)phenyl]quinazoline-6-carboxamide | Formula: | C16 H14 N4 O2 | SMILES: | NC(=O)c1cc2c(N)ncnc2cc1c3cccc(CO)c3 | InChi: | InChI=1S/C16H14N4O2/c17-15-13-5-12(16(18)22)11(6-14(13)19-8-20-15)10-3-1-2-9(4-10)7-21/h1-6,8,21H,7H2,(H2,18,22)(H2,17,19,20) | Definition date: | 2022-06-20 | Last modified: | 2022-09-30 | Release date: | 2022-10-05 | Identifier: | 4-azanyl-7-[3-(hydroxymethyl)phenyl]quinazoline-6-carboxamide |
|
![L6F L6F](https://data.pdbj.org/pdbjplus/data/cc/svg/L6F.svg) | L6F | Name: | (1R)-1-phenyl-1,2,3,4-tetrahydroisoquinolin-5-amine | Formula: | C15 H16 N2 | SMILES: | Nc1cccc2c1CCNC2c1ccccc1 | InChi: | InChI=1S/C15H16N2/c16-14-8-4-7-13-12(14)9-10-17-15(13)11-5-2-1-3-6-11/h1-8,15,17H,9-10,16H2/t15-/m1/s1 | Definition date: | 2022-02-28 | Last modified: | 2022-09-30 | Release date: | 2022-10-05 | Identifier: | (1R)-1-phenyl-1,2,3,4-tetrahydroisoquinolin-5-amine |
|
![L6O L6O](https://data.pdbj.org/pdbjplus/data/cc/svg/L6O.svg) | L6O | Name: | (5R)-N-(4-fluorophenyl)-5-methyl-4,5-dihydro-1,3-thiazol-2-amine | Formula: | C10 H11 F N2 S | SMILES: | CC1CN=C(Nc2ccc(F)cc2)S1 | InChi: | InChI=1S/C10H11FN2S/c1-7-6-12-10(14-7)13-9-4-2-8(11)3-5-9/h2-5,7H,6H2,1H3,(H,12,13)/t7-/m1/s1 | Definition date: | 2022-02-28 | Last modified: | 2022-09-30 | Release date: | 2022-10-05 | Identifier: | (5R)-N-(4-fluorophenyl)-5-methyl-4,5-dihydro-1,3-thiazol-2-amine |
|
![L6U L6U](https://data.pdbj.org/pdbjplus/data/cc/svg/L6U.svg) | L6U | Name: | (2S)-2-{[(2S)-2-({N-[(2,4-dimethoxyphenyl)methyl]glycyl}amino)-2-(thiophen-2-yl)acetyl]amino}-N-methyl-4-phenylbutanamide | Formula: | C28 H34 N4 O5 S | SMILES: | O=C(NC(c1cccs1)C(=O)NC(CCc1ccccc1)C(=O)NC)CNCc1ccc(OC)cc1OC | InChi: | InChI=1S/C28H34N4O5S/c1-29-27(34)22(14-11-19-8-5-4-6-9-19)31-28(35)26(24-10-7-15-38-24)32-25(33)18-30-17-20-12-13-21(36-2)16-23(20)37-3/h4-10,12-13,15-16,22,26,30H,11,14,17-18H2,1-3H3,(H,29,34)(H,31,35)(H,32,33)/t22-,26+/m0/s1 | Definition date: | 2022-02-28 | Last modified: | 2022-09-30 | Release date: | 2022-10-05 | Identifier: | (2S)-2-{[(2S)-2-({N-[(2,4-dimethoxyphenyl)methyl]glycyl}amino)-2-(thiophen-2-yl)acetyl]amino}-N-methyl-4-phenylbutanamide |
|
![L73 L73](https://data.pdbj.org/pdbjplus/data/cc/svg/L73.svg) | L73 | Name: | N-butylglycyl-4-tert-butyl-D-phenylalanyl-3-methoxy-N-methyl-L-phenylalaninamide | Formula: | C30 H44 N4 O4 | SMILES: | COc1cc(CC(NC(=O)C(Cc2ccc(cc2)C(C)(C)C)NC(=O)CNCCCC)C(=O)NC)ccc1 | InChi: | InChI=1S/C30H44N4O4/c1-7-8-16-32-20-27(35)33-26(18-21-12-14-23(15-13-21)30(2,3)4)29(37)34-25(28(36)31-5)19-22-10-9-11-24(17-22)38-6/h9-15,17,25-26,32H,7-8,16,18-20H2,1-6H3,(H,31,36)(H,33,35)(H,34,37)/t25-,26+/m0/s1 | Definition date: | 2022-02-28 | Last modified: | 2022-09-30 | Release date: | 2022-10-05 | Identifier: | N-butylglycyl-4-tert-butyl-D-phenylalanyl-3-methoxy-N-methyl-L-phenylalaninamide |
|
![L8K L8K](https://data.pdbj.org/pdbjplus/data/cc/svg/L8K.svg) | L8K | Name: | 3,3-dimethyl-1-{[(9aM)-9-propyl-5,6-dihydrothieno[3,4-h]quinazolin-2-yl]sulfanyl}butan-2-one | Formula: | C19 H24 N2 O S2 | SMILES: | CC(C)(C)C(=O)CSc1nc2c(CCc3csc(CCC)c23)cn1 | InChi: | InChI=1S/C19H24N2OS2/c1-5-6-14-16-13(10-23-14)8-7-12-9-20-18(21-17(12)16)24-11-15(22)19(2,3)4/h9-10H,5-8,11H2,1-4H3 | Definition date: | 2022-03-01 | Last modified: | 2022-09-30 | Release date: | 2022-10-05 | Identifier: | 3,3-dimethyl-1-{[(9aM)-9-propyl-5,6-dihydrothieno[3,4-h]quinazolin-2-yl]sulfanyl}butan-2-one |
|
![L8R L8R](https://data.pdbj.org/pdbjplus/data/cc/svg/L8R.svg) | L8R | Name: | 3,3-dimethyl-1-{[(9aM)-9-propyl-5,6-dihydrothieno[2,3-h]quinazolin-2-yl]sulfanyl}butan-2-one | Formula: | C19 H24 N2 O S2 | SMILES: | CC(C)(C)C(=O)CSc1ncc2CCc3scc(CCC)c3c2n1 | InChi: | InChI=1S/C19H24N2OS2/c1-5-6-13-10-23-14-8-7-12-9-20-18(21-17(12)16(13)14)24-11-15(22)19(2,3)4/h9-10H,5-8,11H2,1-4H3 | Definition date: | 2022-03-01 | Last modified: | 2022-09-30 | Release date: | 2022-10-05 | Identifier: | 3,3-dimethyl-1-{[(9aM)-9-propyl-5,6-dihydrothieno[2,3-h]quinazolin-2-yl]sulfanyl}butan-2-one |
|
![L9E L9E](https://data.pdbj.org/pdbjplus/data/cc/svg/L9E.svg) | L9E | Name: | N-(3-azanylpropyl)-3-[[(3S)-1-(2-fluorophenyl)-2-oxidanylidene-pyrrolidin-3-yl]amino]-N-methyl-benzamide | Formula: | C21 H25 F N4 O2 | SMILES: | CN(CCCN)C(=O)c1cccc(N[CH]2CCN(C2=O)c3ccccc3F)c1 | InChi: | InChI=1S/C21H25FN4O2/c1-25(12-5-11-23)20(27)15-6-4-7-16(14-15)24-18-10-13-26(21(18)28)19-9-3-2-8-17(19)22/h2-4,6-9,14,18,24H,5,10-13,23H2,1H3/t18-/m0/s1 | Synonyms: | (S)-N-(3-aminopropyl)-3-((1-(2-fluorophenyl)-2-oxopyrrolidin-3-yl)amino)-N-methylbenzamide | Definition date: | 2022-06-27 | Last modified: | 2022-09-30 | Release date: | 2022-10-05 | Identifier: | ~{N}-(3-azanylpropyl)-3-[[(3~{S})-1-(2-fluorophenyl)-2-oxidanylidene-pyrrolidin-3-yl]amino]-~{N}-methyl-benzamide |
|
![8KF 8KF](https://data.pdbj.org/pdbjplus/data/cc/svg/8KF.svg) | 8KF | Name: | 2-[(9H-carbazol-3-yl)amino]-5-(trifluoromethyl)benzoic acid | Formula: | C20 H13 F3 N2 O2 | SMILES: | FC(F)(F)c1ccc(Nc2cc3c4ccccc4[NH]c3cc2)c(c1)C(=O)O | InChi: | InChI=1S/C20H13F3N2O2/c21-20(22,23)11-5-7-18(15(9-11)19(26)27)24-12-6-8-17-14(10-12)13-3-1-2-4-16(13)25-17/h1-10,24-25H,(H,26,27) | Definition date: | 2021-09-22 | Last modified: | 2022-09-30 | Release date: | 2022-10-05 | Identifier: | 2-[(9H-carbazol-3-yl)amino]-5-(trifluoromethyl)benzoic acid |
|
![8KQ 8KQ](https://data.pdbj.org/pdbjplus/data/cc/svg/8KQ.svg) | 8KQ | Name: | 2-{[(3R)-2,3,4,9-tetrahydro-1H-carbazol-3-yl]amino}-5-(trifluoromethyl)benzoic acid | Formula: | C20 H17 F3 N2 O2 | SMILES: | FC(F)(F)c1ccc(NC2Cc3c4ccccc4[NH]c3CC2)c(c1)C(=O)O | InChi: | InChI=1S/C20H17F3N2O2/c21-20(22,23)11-5-7-18(15(9-11)19(26)27)24-12-6-8-17-14(10-12)13-3-1-2-4-16(13)25-17/h1-5,7,9,12,24-25H,6,8,10H2,(H,26,27)/t12-/m1/s1 | Definition date: | 2021-09-22 | Last modified: | 2022-09-30 | Release date: | 2022-10-05 | Identifier: | 2-{[(3R)-2,3,4,9-tetrahydro-1H-carbazol-3-yl]amino}-5-(trifluoromethyl)benzoic acid |
|
![GJF GJF](https://data.pdbj.org/pdbjplus/data/cc/svg/GJF.svg) | GJF | Name: | (1~{R},3~{S},6~{R},8~{R},9~{R},10~{S},12~{S},15~{R},17~{R},18~{R})-8,17-bis(6-aminopurin-9-yl)-3,12-bis(oxidanylidene)-3,12-bis(sulfanyl)-2,4,7,11,13,16-hexaoxa-3$l^{5},12$l^{5}-diphosphatricyclo[13.2.1.0^{6,10}]octadecane-9,18-diol | Formula: | C20 H24 N10 O10 P2 S2 | SMILES: | Nc1ncnc2n(cnc12)[CH]3O[CH]4CO[P](S)(=O)O[CH]5[CH](O)[CH](CO[P](S)(=O)O[CH]4[CH]3O)O[CH]5n6cnc7c(N)ncnc67 | InChi: | InChI=1S/C20H24N10O10P2S2/c21-15-9-17(25-3-23-15)29(5-27-9)19-12(32)13-8(38-19)2-36-42(34,44)40-14-11(31)7(1-35-41(33,43)39-13)37-20(14)30-6-28-10-16(22)24-4-26-18(10)30/h3-8,11-14,19-20,31-32H,1-2H2,(H,33,43)(H,34,44)(H2,21,23,25)(H2,22,24,26)/t7-,8-,11-,12-,13-,14-,19-,20-,41+,42+/m1/s1 | Definition date: | 2022-05-15 | Last modified: | 2022-09-30 | Release date: | 2022-10-05 | Identifier: | (1~{R},3~{S},6~{R},8~{R},9~{R},10~{S},12~{S},15~{R},17~{R},18~{R})-8,17-bis(6-aminopurin-9-yl)-3,12-bis(oxidanylidene)-3,12-bis(sulfanyl)-2,4,7,11,13,16-hexaoxa-3$l^{5},12$l^{5}-diphosphatricyclo[13.2.1.0^{6,10}]octadecane-9,18-diol |
|
![JYO JYO](https://data.pdbj.org/pdbjplus/data/cc/svg/JYO.svg) | JYO | Name: | (4~{S})-4-(2-azanylethyl)-6-phenyl-7-[3-(trifluoromethyloxy)phenyl]-3,4-dihydropyrrolo[1,2-a]pyrazin-1-ol | Formula: | C22 H20 F3 N3 O2 | SMILES: | NCC[CH]1CN=C(O)c2cc(c3cccc(OC(F)(F)F)c3)c(n12)c4ccccc4 | InChi: | InChI=1S/C22H20F3N3O2/c23-22(24,25)30-17-8-4-7-15(11-17)18-12-19-21(29)27-13-16(9-10-26)28(19)20(18)14-5-2-1-3-6-14/h1-8,11-12,16H,9-10,13,26H2,(H,27,29)/t16-/m0/s1 | Definition date: | 2022-05-16 | Last modified: | 2022-09-30 | Release date: | 2022-10-05 | Identifier: | (4~{S})-4-(2-azanylethyl)-6-phenyl-7-[3-(trifluoromethyloxy)phenyl]-3,4-dihydropyrrolo[1,2-a]pyrazin-1-ol |
|
![MF6 MF6](https://data.pdbj.org/pdbjplus/data/cc/svg/MF6.svg) | MF6 | Name: | (1S,3R,4R,6R,9S,11R,14R,15S,16R,18R)-4-(6-amino-9H-purin-9-yl)-9,11,15,16,18-pentahydroxy-2,5,8,10,12,17-hexaoxa-9lambda~5~,11lambda~5~-diphosphatricyclo[12.2.1.1~3,6~]octadecane-9,11-dione | Formula: | C15 H21 N5 O13 P2 | SMILES: | Nc1ncnc2c1ncn2C1OC2COP(=O)(O)OP(=O)(O)OCC3OC(OC1C2O)C(O)C3O | InChi: | InChI=1S/C15H21N5O13P2/c16-12-7-13(18-3-17-12)20(4-19-7)14-11-9(22)6(30-14)2-29-35(26,27)33-34(24,25)28-1-5-8(21)10(23)15(31-5)32-11/h3-6,8-11,14-15,21-23H,1-2H2,(H,24,25)(H,26,27)(H2,16,17,18)/t5-,6-,8-,9-,10-,11-,14-,15+/m1/s1 | Synonyms: | 1'-2' gcADPR | Definition date: | 2022-03-16 | Last modified: | 2022-09-30 | Release date: | 2022-10-05 | Identifier: | (1S,3R,4R,6R,9S,11R,14R,15S,16R,18R)-4-(6-amino-9H-purin-9-yl)-9,11,15,16,18-pentahydroxy-2,5,8,10,12,17-hexaoxa-9lambda~5~,11lambda~5~-diphosphatricyclo[12.2.1.1~3,6~]octadecane-9,11-dione |
|
![1LT 1LT](https://data.pdbj.org/pdbjplus/data/cc/svg/1LT.svg) | 1LT | Name: | (2S)-N~1~-{4-methyl-5-[2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridin-4-yl]-1,3-thiazol-2-yl}pyrrolidine-1,2-dicarboxamide | Formula: | C19 H22 F3 N5 O2 S | SMILES: | O=C(Nc1nc(c(s1)c2ccnc(c2)C(C)(C)C(F)(F)F)C)N3C(C(=O)N)CCC3 | InChi: | InChI=1S/C19H22F3N5O2S/c1-10-14(11-6-7-24-13(9-11)18(2,3)19(20,21)22)30-16(25-10)26-17(29)27-8-4-5-12(27)15(23)28/h6-7,9,12H,4-5,8H2,1-3H3,(H2,23,28)(H,25,26,29)/t12-/m0/s1 | Synonyms: | Alpelisib | Definition date: | 2013-03-22 | Last modified: | 2022-09-30 | Release date: | 2014-04-02 | Identifier: | (2S)-N~1~-{4-methyl-5-[2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridin-4-yl]-1,3-thiazol-2-yl}pyrrolidine-1,2-dicarboxamide |
|
![K6L K6L](https://data.pdbj.org/pdbjplus/data/cc/svg/K6L.svg) | K6L | Name: | [(2~{R})-2-[5-(2-hexylphenyl)pentanoylamino]-3-oxidanyl-propyl] dihydrogen phosphate | Formula: | C20 H34 N O6 P | SMILES: | CCCCCCc1ccccc1CCCCC(=O)N[CH](CO)CO[P](O)(O)=O | InChi: | InChI=1S/C20H34NO6P/c1-2-3-4-5-10-17-11-6-7-12-18(17)13-8-9-14-20(23)21-19(15-22)16-27-28(24,25)26/h6-7,11-12,19,22H,2-5,8-10,13-16H2,1H3,(H,21,23)(H2,24,25,26)/t19-/m1/s1 | Definition date: | 2022-09-11 | Last modified: | 2022-09-30 | Release date: | 2022-10-05 | Identifier: | [(2~{R})-2-[5-(2-hexylphenyl)pentanoylamino]-3-oxidanyl-propyl] dihydrogen phosphate |
|
![82Q 82Q](https://data.pdbj.org/pdbjplus/data/cc/svg/82Q.svg) | 82Q | Name: | (2~{R},4~{R})-1-ethanoyl-~{N}-naphthalen-1-yl-4-phenyl-pyrrolidine-2-carboxamide | Formula: | C23 H22 N2 O2 | SMILES: | CC(=O)N1C[CH](C[CH]1C(=O)Nc2cccc3ccccc23)c4ccccc4 | InChi: | InChI=1S/C23H22N2O2/c1-16(26)25-15-19(17-8-3-2-4-9-17)14-22(25)23(27)24-21-13-7-11-18-10-5-6-12-20(18)21/h2-13,19,22H,14-15H2,1H3,(H,24,27)/t19-,22+/m0/s1 | Definition date: | 2021-09-28 | Last modified: | 2022-09-30 | Release date: | 2022-10-05 | Identifier: | (2~{R},4~{R})-1-ethanoyl-~{N}-naphthalen-1-yl-4-phenyl-pyrrolidine-2-carboxamide |
|